Calidi Biotherapeutics CLDI
NYSE CLDI
$0.67 -0.01 (-0.78%)
As of: Nov 12, 2026 · 11:30 AM EST

Calidi Biotherapeutics (CLDI) Interest & Investment Income (2022 - 2023)

Updated

Calidi Biotherapeutics (CLDI) reported Interest & Investment Income of $1.09 million for Q3 2022, up 581.9% from the prior quarter.

Analysis

Calidi Biotherapeutics (CLDI) Interest & Investment Income (2022 - 2023) Analysis & Trends

For FY2021, Calidi Biotherapeutics posted Interest & Investment Income of $1,669.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Calidi Biotherapeutics 991,199.98 -25.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 493,561.00
Mar 31, 2023 425,850.00
Dec 31, 2022 357,737.00
Sep 30, 2022 1.09 Mn
Jun 30, 2022 159,999.00
Mar 31, 2022 16,505.00
API Access

Calidi Biotherapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CLDI&period=max&api_key=YOUR_API_KEY